LabCorp's Esoteric Testing Grew 7 Percent in Q3 as Total Revenues Rose 7.7 Percent

Around 37 percent of the lab's total revenue, or around $48 billion, came from genomic, esoteric, and anatomic-pathology testing, while revenue per requisition rose 5.7 percent. However, the lab cut its 2010 revenue guidance.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.